Suzuki M, Wakabayashi K, Sone H, Kushida H, Sugiyama K, Kakizoe T, Nagao M, Sugimura T
National Cancer Center Research Institute, Tokyo.
Jpn J Cancer Res. 1991 Apr;82(4):386-9. doi: 10.1111/j.1349-7006.1991.tb01860.x.
A derivative of ascorbic acid, 2-O-octadecylascorbic acid (CV-3611), is a strong scavenger of active oxygen species. We examined the effect of CV-3611 on a short-term test of bladder carcinogenesis, using concanavalin A (Con A)-dependent agglutination of isolated bladder epithelial cells. Rats were given 0.01% N-butyl-N-(4-hydroxybutyl)nitrosamine (BHBN) for 1 week, and then 5% sodium saccharin or 2% DL-tryptophan or 0.01% BHBN alone or with 0.002, 0.006 or 0.02% CV-3611 for 3 weeks. Treatment with CV-3611 reduced the effects of the bladder tumor promoters sodium saccharin and DL-tryptophan by 48-86 and 65-87%, respectively. CV-3611 also reduced the number of aggregates of bladder epithelial cells from rats treated with BHBN for 4 weeks. These results suggest that CV-3611 has a suppressive effect on rat bladder carcinogenesis.
抗坏血酸的衍生物2-O-十八烷基抗坏血酸(CV-3611)是活性氧物种的强力清除剂。我们使用伴刀豆球蛋白A(Con A)依赖的分离膀胱上皮细胞凝集法,研究了CV-3611对膀胱致癌作用短期试验的影响。给大鼠喂食0.01%的N-丁基-N-(4-羟丁基)亚硝胺(BHBN)1周,然后分别单独喂食5%的糖精钠或2%的DL-色氨酸或0.01%的BHBN,或同时添加0.002%、0.006%或0.02%的CV-3611,持续3周。CV-3611处理分别使膀胱肿瘤促进剂糖精钠和DL-色氨酸的作用降低了48 - 86%和65 - 87%。CV-3611还减少了用BHBN处理4周的大鼠膀胱上皮细胞聚集体的数量。这些结果表明,CV-3611对大鼠膀胱致癌作用具有抑制效果。